Dysregulation of Drp1 is associated with neurodegenerative diseases such as Alzheimer’s (Cho et al, 2009; Wang et al, 2009), Huntington’s (Song et al, 2011; Shirendeb et al, 2012), or Parkinson’s (Han et al, 2020) as well as cardiovascular diseases (Nan et al, 2017; Jin et al, 2021). This evidence concerns the gene DNM1L and Parkinson disease.